Essential tremor. Epidemiology, diagnosis, and treatment. Neurologist 2004;10:250-258.
Sullivan, KL, RA Hauser, and TA Zesiewicz. 2004. “Essential Tremor. Epidemiology, Diagnosis, and Treatment. Neurologist 2004;10:250-258.”. Neurologist.
Search
Search results
356 results found
Double-blinded, placebo-controlled study of entacapone in levodopa-treated patients with Parkinson disease. Archives of neurology, 61(10), 1563.
Olanow, CW, K Kieburtz, M Stern, R Watts, JW Langston, M Guarnieri, RA Hauser, and J Hubble. 2004. “Double-Blinded, Placebo-Controlled Study of Entacapone in Levodopa-Treated Patients With Parkinson Disease. Archives of Neurology, 61(10), 1563.”. Archives of Neurology.
Autonomic nervous system dysfunction in Parkinson’s disease. Curr Treat Options Neurol 2003; 5:149-160.
Zesiewicz, TA, MJ Baker, M Wahba, and RA Hauser. 2003. “Autonomic Nervous System Dysfunction in Parkinson’s Disease. Curr Treat Options Neurol 2003; 5:149-160.”. Curr Treat Options Neurol.
Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson’s disease.
Kase, H, S Aoyama, M Ichimura, K Ikeda, A Ishii, T Kanda, K Koga, and . 2003. “Progress in Pursuit of Therapeutic A2A Antagonists: the Adenosine A2A Receptor Selective Antagonist KW6002: Research and Development Toward a Novel Nondopaminergic Therapy for Parkinson’s Disease.”. Neurology.
Randomized trial of the adenosine A2A receptor antagonist istradefylline in advanced PD. Neurology 2003;61:297-303.
Hauser, RA, JP Hubble, and DD Truong. 2003. “Randomized Trial of the Adenosine A2A Receptor Antagonist Istradefylline in Advanced PD. Neurology 2003;61:297-303.”. Neurology.
Driving safety in Parkinson’s disease. Neurology 2002;59:1787-1788.
Zesiewicz, TA, CR Cimino, AR Malek, N Gardner, PL Leaverton, PB Dunne, and RA Hauser. 2002. “Driving Safety in Parkinson’s Disease. Neurology 2002;59:1787-1788.”. Neurology.
Cyclosporine-A increases locomotor activity in rats with 6-hydroxydopamine-induced hemiparkinsonism: relevance to neural transplantation. Surgical Neurology 1996;46:384-388.
Borlongan, CV, TB Freeman, RA Hauser, DW Cahill, and PR Sanberg. 1996. “Cyclosporine-A Increases Locomotor Activity in Rats With 6-Hydroxydopamine-Induced Hemiparkinsonism: Relevance to Neural Transplantation. Surgical Neurology 1996;46:384-388.”. Surgical Neurology.
Oro-buccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson’s disease. Movement Disorders 1993;8:512-514.
Hauser, RA, and CW Olanow. 1993. “Oro-Buccal Dyskinesia Associated With Trihexyphenidyl Therapy in a Patient With Parkinson’s Disease. Movement Disorders 1993;8:512-514.”. Movement Disorders.
Intramedullary spinal cord sarcoidosis mimicking glioma by magnetic resonance imaging. Paraplegia 1991;29:203-206.
Hauser, RA, SL Alden, and . 1991. “Intramedullary Spinal Cord Sarcoidosis Mimicking Glioma by Magnetic Resonance Imaging. Paraplegia 1991;29:203-206.”. Paraplegia.
Hauser RA, Zesiewicz TA. Sertraline for the treatment of depression in Parkinson’s disease. Movement Disorders 1997;12:756-759.
Hauser, RA, and TA Zesiewicz. 1997. “Hauser RA, Zesiewicz TA. Sertraline for the Treatment of Depression in Parkinson’s Disease. Movement Disorders 1997;12:756-759.”. Movement Disorders.